摘要:
The present invention relates to dissolved silicate compositions in which the dissolved silicate is stabilized by at least two selected osmolytes and is therefore bioavailable. The composition and its dilutions are stable over a long period of time and are used in a wide field of applications for the benefit of living organisms such as plants, animals and humans.
摘要:
A composition suitable for improving seed quality in a plant comprising: (i) a compound selected from an auxin, an auxin precursor, an auxin metabolite or a derivative of said auxin, auxin precursor or auxin metabolite; (ii) acetaminophen or a derivative thereof; and further comprising at least one compound selected from (iiϊ) to (v) wherein: (iii) is a cytokinin, (iv) is another agrochemically acceptable additive, and (v) is a thiosulphate.
摘要:
A composition comprising a compound selected from an auxin, an auxin precursor, an auxin metabolite or a derivative of said auxin, auxin precursor or auxin metabolite or a mixture thereof and acetaminophen or a derivative thereof for use as a chemical thinning agent.
摘要:
The present invention relates to a process for preparing secondary amides with good selectivity by carbonylating a corresponding tertiary amine with carbon monoxide in a reaction mixture in the presence of a metal catalyst and in the presence of a halogen containing promoter. The metal catalyst comprises palladium. A same or even a much better catalytic activity can be obtained with palladium than with the much more expensive rhodium, especially when the palladium is used in a low concentration. Moreover, also a good selectivity can be achieved.
摘要:
The invention relates to a method for the non-therapeutic treatment of poultry for the purpose of reducing the conversion rate of the feed used to raise the poultry. The treatment comprises orally administering at least one glycine compound to the poultry, which glycine compound corresponds to the following formula (I) or to a salt thereof : wherein R1 and R2 are independently an alkyl, an alkenyl or a hydroxyalkyl radical containing 1 to 18, preferably 1 to 6 carbon atoms or wherein R1 and R2 form jointly together with the N atom a heterocyclic 5- or 6-membered ring. The glycine compound is preferably N, N-dimethylglycine (DMG). The invention also relates to the therapeutic and second medical use of that glycine compound to reduce the incidence of ascites, and to a feed for poultry containing an amount of that glycine compound.